Director’s trust adds 2,030 Insulet (PODD) shares at $246.23 each

Rhea-AI Filing Summary

INSULET CORP director-related trust buys additional shares. On February 25, 2026, a trust associated with director Michael R. Minogue purchased 2,030 shares of Insulet common stock in open-market transactions at a weighted average price of $246.23 per share. After this, the trust held 17,483 shares indirectly, while Minogue also held 778 shares directly.

Insider Trade Summary

Net Buyer: 2,030 shares ($499,847)

Net Buy 2 txns

Insider MINOGUE MICHAEL R

Role Director

Bought 2,030 shs ($500K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	2,030	$246.23	$500K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 17,483 shares (Indirect, By Trust); Common Stock — 778 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MINOGUE MICHAEL R

(Last) (First) (Middle)

C/O INSULET CORPORATION

100 NAGOG PARK

(Street)

ACTON MA 01720

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		P		2,030	A	$246.23(1)	17,483	I	By Trust
Common Stock								778	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported represents the weighted average purchase price of the shares acquired. The shares were purchased in multiple transactions at prices ranging from $246.04 to $246.42. The Reporting Person hereby undertakes, upon the request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.

	/s/ Patricia K. Dolan, attorney-in-fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Insulet (PODD) report for Michael R. Minogue?

Insulet reported that a trust associated with director Michael R. Minogue bought 2,030 shares of common stock. The purchase occurred in open-market transactions at a weighted average price of $246.23 per share, increasing the trust’s indirect holdings to 17,483 shares.

How many Insulet (PODD) shares did the director-related trust buy and at what price?

The trust associated with director Michael R. Minogue bought 2,030 Insulet common shares. The weighted average purchase price was $246.23 per share, based on multiple trades executed between $246.04 and $246.42, as detailed in the filing footnote.

What are Michael R. Minogue’s direct and indirect Insulet (PODD) holdings after the transaction?

After the reported transaction, Michael R. Minogue directly held 778 Insulet common shares. Indirectly, through a trust, 17,483 Insulet common shares were held, reflecting the 2,030 shares purchased on February 25, 2026, in open-market transactions.

When did the latest Insulet (PODD) insider share purchase by the director-related trust occur?

The latest share purchase tied to director Michael R. Minogue’s trust occurred on February 25, 2026. On that date, the trust acquired 2,030 Insulet common shares in open-market trades at a weighted average price of $246.23 per share.

How were the purchase prices for the Insulet (PODD) director-related trust transaction determined?

The filing states the reported $246.23 price is a weighted average of multiple trades. Individual trades for the 2,030 shares occurred at prices ranging from $246.04 to $246.42, and detailed breakdowns are available upon request from appropriate parties.